Suven Life Sciences rises 5% on product patents in Eurasia Norway News News / News 6 years ago 448 Views comments The patents are for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2034 and 2026 respective... Read more
News Buy Reliance Industries, HUL, Reliance Capital, SREI Infra, SRF: Ashwani Gujral News / News - 6 years ago
News Buy Edelweiss Financial, Future Lifestyle; sell Eicher Motors: Ashwani Gujral News / News - 6 years ago
Comments